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INTRODUCTION 
Rational drug use (RDU) is the use of drugs that are in 
accordance with the criteria, such as the right medicine, 
the right diagnosis, the right indication, how to use it, the 
time of administration, the right condition of the patient, 
timely administration and alert to side effects (Smeulers 
et al., 2015). World Health Organization (WHO) estimates 
that almost more than half of all drugs in the world are 
given, sold and prescribed inappropriately, and half of 
the patient’s misuse drugs (Ministry of Health of the 
Republic of Indonesia, 2017). Where it is known that 
irrational use of drugs, as well as negative impacts, is 
greater than the benefits, received by patients, side effects 
and antibiotic resistance occur, besides the costs are not 
affordable/too expensive (Ofori-Asenso & Agyeman, 
2016). Medication prescription is usually done as the last 
step in patient and doctor consultation, but there are still 
frequent therapeutic errors (medication errors)/therapy 
(FitzGerald, 2009). This error usually occurs in 
prescribing, where when choosing the type of drug, 
dosage, how to use it, writing is challenging to read, 
where the incident becomes a supporting factor in 
increasing therapeutic errors (Simatupang, 2012). 
Rational Drug Use is one of the things that needs to be 
done to get maximum treatment (Basaran & Akici, 2012). 
Evaluation of RDU is reviewed from prescription based 
on disease, according to Ministry of Health of the 
Republic of Indonesia (2017), which has been listed using 
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 Abstract 
Rational drug use (RDU) is an indicator to evaluates a treatment given 
to patients, like proper medication, precise diagnosis, precise dosing. 
Community Health Center (CHC) has the risk of irrational drug use. 
In this study, researchers selected N and BL CHC, aiming to evaluate 
the prescribing indicators based on three diseases which are non-
pneumonia acute respiratory infection (ARI), non-specific diarrhea and 
myalgia, and the facility indicators with DOEN (list of essential 
national medicines) availability and 20 mandatory drugs. This 
research was a descriptive-analytical study with cross-sectional 
methods where the data retrieval of the prescribing is taken from 
January to December 2018. The study used the normality test and 
homogeneity test before independent sample T-test, from the third 
outcome of the test, the N and BL CHC could be said to differ 
significantly of RDU. It can be concluded that rational drug use is 
reviewed from a prescribing indicator based on disease and facility 
indicator. The results of RDU are rational in N CHC, in contrast with 
BL CHC which is not rational with the results of the RDU in N CHC is 
101.44% and BL CHC is 89.81%. The results of N CHC is better than 
BL CHC, which both CHCs have fulfilled the target of the government, 
for 68% in 2018. In both CHCs for the facility indicator, there are a 
DOEN and 20 essential medicines. 
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three diseases, namely non-pneumonia acute respiratory 
infection (ARI), non-specific diarrhea and Myalgia, 
besides according to the Semarang City Health Office, 
that three diseases are included prevalence of the top 10 
diseases in Semarang Community Health Center (CHC) 
in 2017. In the RDU module, it said in the facility 
indicators there was three-module which is patient 
knowledge about the correct dosage, availability of 
Essential Medication List (DOEN), and availability of 
critical drugs (Ministry of Health of the Republic of 
Indonesia, 2013). Here the researcher uses two facility 
indicators, namely the availability of a List of Essential 
Medicines and critical drugs. 
The Community Health Center is one type of first-level 
health care facility that has an essential role in the national 
health system, specifically the health efforts subsystem, 
seeing that the CHC has a significant risk of irrational use 
of drugs (Ofori-Asenso & Agyeman, 2016). Here, the 
researchers choose the N and BL CHC for data collection 
related to the evaluation of RDU in terms of prescription 
based on diseases and facilities, as for the reasons for 
choosing the N and BL CHC, namely at the two CHCs 
which were the largest in the sub-district. The BL CHC is 
located in North Semarang Subdistrict, while the N CHC 
is in West Semarang Subdistrict. Also, the two CHCs are 
both in urban areas and at the two CHCs are in densely 
populated areas, for the BL CHC has a population of 
51,889 people and N CHC 46,383 people, besides that the 
two CHCs have never been evaluated before (Semarang 
City Health Office, 2015). 
The research was conducted aimed at looking at the 
rationality in the use of drugs in Semarang City CHC, 
two of them is N and BL CHC, by looking at three 
diseases, namely non-pneumonia ARI, non-specific 
diarrhea and Myalgia, known in the three diseases 
including the top ten diseases often found in CHC, 
besides that, also looking at the facilities, to see whether 
or not there is a DOEN or 20 essential medicines for the 
CHC. 
 
MATERIALS AND METHODS 
This study was an analytical descriptive study using the 
cross-sectional method. Retrospective method for 
retrieving prescription indicator data and prospecting for 
facility indicator data collection. Free variables are 
prescribing indicators and RDU facilities, while for 
Bound variables are RDU. 
The population of this study is the number of all 
prescriptions from all diseases in one year in January - 
December of 2018 in N and BL CHC of Semarang City. 
From the total number of prescription samples in N and 
BL CHC that will be taken, those that meet the inclusion 
criteria. Data analysis was performed using statistical test 
software. The α value used is 5% because the researcher 
used a 95% confidence interval. 
 
RESULTS AND DISCUSSION 
Data collection was carried out in the two CHCs from 
January to December 2018, in N CHC there were 4,739 
prescriptions for all three diseases, respectively for non-
pneumonia ARI 2,709 prescriptions, non-specific 
diarrhea 672 prescriptions and Myalgia 1,358 
prescriptions. Whereas for BL CHC for all prescriptions 
for the three diseases, 3,761 prescriptions and each 
disease were found in non-pneumonia ARI 2,583 
prescriptions, non-specific diarrhea 363 prescriptions, 
Myalgia 815 prescriptions, if seen from the working area 
at BL CHC of 51,130 people, whereas in N CHC is 55,739 
people. This makes N CHC having more prescriptions in 
2018 than BL CHC. 
In prescribing data taken at N and BL CHC, total 
prescriptions were obtained for the three diseases, of 
which N CHC had a more significant total prescription 
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for the three diseases, compared to BL CHC. The data is 
presented in Table I. 
Table I. Total prescription for N and BL CHC during 2018 
Type of disease 
Number of Prescription 
N CHC BL CHC 
Non-pneumonia ARI 2,709 2,583 
Non-specific diarrhea 672 363 
Myalgia 1,358 815 
Total prescriptions 4,739 3,761 
 
Data retrieval is done in a retrospective manner from 
January to December 2018 for prescription, while for 
prospective indicators of facility collection. After 
retrieving the data, it is then processed using Microsoft 
Excel to find out the results of the percentage of antibiotic 
use in non-pneumonia ARI and non-specific diarrhea 
and the use of injection of Myalgia, mean drug items and 
percentage of RDU. The maximum use of antibiotics in 
non-pneumonia ARI is 20%, non-specific diarrhea is 8%, 
and injection of Myalgia is 1%, while for average drug 
items is a prescription of 2.6 (Ministry of Health of the 
Republic of Indonesia, 2017). 
The use of antibiotics in non-pneumonia ARI at the BL 
CHC is more than the parameters. The parameter for 
non-pneumonia ARI is a maximum of 20% according to 
the Ministry of Health of the Republic of Indonesia (2017), 
which is only in January, July and October that do not 
meet the parameters. In processing the data, which is 
obtained from the percentage of the use of non-
pneumonia ARI antibiotics in N CHC is stated rationally 
on a monthly basis which is less than 20% while in BL 
CHC there are three months which are declared 
irrational in antibiotic use, and nine months are said to 
meet from the parameter. This happens because of the 
frequent administration of antibiotics in non-pneumonia 
ARI which does not need antibiotics because non-
pneumonia ARI is a disease caused by viruses or 
commonly known in the community with the common 
cold (Sauriasari et al., 2017). It is said that N CHC is 
rational because the prescription is taken according to the 
requirements, i.e. without any disease or accompanying 
diagnosis in each prescription, besides that the doctor 
does not give antibiotics but not all, which still found 
some who use antibiotics in some prescription. The data 
on antibiotic use for non-pneumonia ARI are presented 
in Table II. 
Table II. Percentage of antibiotic use in non-pneumonia ARI 
in N and BL CHC Semarang 
No Month 
N CHC BL CHC 
Amount % Amount % 
1 January 9 3.22 37 23.56* 
2 February 7 2.92 44 16.60 
3 March 8 2.2 68 18.18 
4 April 7 3.11 19 8.29 
5 May 6 3.07 37 14.56 
6 June 5 4.06 23 15.43 
7 July 7 3.25 51 24.05* 
8 August 6 2.4 42 16.66 
9 September 7 3.64 23 16.42 
10 October 6 3.46 41 20.29* 
11 November 6 2.88 40 18.43 
12 December 8 3.22 17 12.87 
Average  3.12  17.11 
Note: * irrational 
Antibiotics are still often found in non-specific diarrhea at 
BL compared to N CHC. The parameters for non-specific 
diarrhea are a maximum of 8% and only in March, May 
and September that the parameters are met, and the rest 
do not meet the parameters. The use of non-specific 
Diarrhea antibiotics in N CHC was expressed according 
to parameters, whereas in BL CHC, nine months did not 
meet the parameters in 2018. Where the percentage of 
antibiotic use in non-specific diarrhea was a maximum of 
8% (Ministry of Health of the Republic of Indonesia, 
2017). Non-specific diarrhea is caused by rotavirus, 
which can heal on its own (Crawford et al., 2017). In 
interviews with pharmacists in N CHC, they fulfilled the 
parameters because from the pharmacy department itself 
was polluting each prescription, other than that the 
authorized person was very rarely given antibiotics, 
which were usually given Oral Rehydration Solutions 
(ORS) and zinc. Data on antibiotic use for non-specific 
diarrhea are presented in Table III. 
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Table III. Percentage of antibiotic use in non-specific diarrhea 
in N and BL CHC Semarang 
No Month 
N CHC BL CHC 
Amount % Amount % 
1 January 3 3.89 5 21.73* 
2 February 2 3.92 8 18.18* 
3 March 2 3.84 3 6.38 
4 April 2 3.77 3 11.53* 
5 May 2 4 0 0 
6 June 2 3.63 2 15.38* 
7 July 2 3.38 2 7.14 
8 August 2 3.38 9 24.32* 
9 September 2 3.7 5 25* 
10 October 2 3.63 8 26.66* 
11 November 2 3.57 9 28.12* 
12 December 2 3.92 6 19.35* 
Average  3.76  16.98* 
Note: * irrational 
In the injection of Myalgia, the results for both CHCs met 
the parameters, where the parameters for Myalgia were 
1% (Ministry of Health of the Republic of Indonesia, 
2017). As for the second yield of CHC is 0%. This 
happened because there had been no injection of Myalgia 
since a long time ago. In addition, the role of the 
government which was suppressing high injection 
through the procurement of drugs, among others, 
knowledge from the community and doctors who went 
to the doctor did not have to be injected (Kardela et al., 
2014), especially sometimes elderly patients have an 
illness which cannot be given injection by injection and 
also there is no injection drug available for my happiness 
in both CHCs. In both CHCs, no injection was given for 
the injection, but sometimes in CHC in the 
administration of the drug, there were still up to four 
types of drugs, such as (neurovitamin/B1, B6, B12 + 
analgesic). Data on injection use for Myalgia are 
presented in Table IV. 
Table IV. Percentage of injection use in Myalgia in N and BL 
CHC Semarang 
No Month 
N CHC BL CHC 
Amount % Amount % 
1 January 0 0 0 0 
2 February 0 0 0 0 
3 March 0 0 0 0 
4 April 0 0 0 0 
5 May 0 0 0 0 
6 June 0 0 0 0 
7 July 0 0 0 0 
8 August 0 0 0 0 
9 September 0 0 0 0 
10 October 0 0 0 0 
11 November 0 0 0 0 
12 December 0 0 0 0 
Average  0  0 
 
In the results of the average item per prescription sheet, 
the two CHCs did not meet the parameters, only one 
month fulfilled the parameters, namely in March with 
1.96 item per prescription in BL CHC, whereas in N CHC 
in one year there were no parameters. The parameters for 
the average item per sheet are a prescription maximum 
of 2.6 (Ministry of Health of the Republic of Indonesia, 
2017). This is likely to occur due to the presence of 
polypharmacy at each CHC, which sometimes doctors 
focus more on symptoms that occur than diagnoses or 
information obtained is lacking (Kukreja et al., 2013). 
Besides, the results of interviews with pharmacists in N 
CHC, where patients feel that the administration of a 
small number of drugs (2/3 of the drugs) is considered 
insufficient so that the pharmacist gives additional drugs, 
which is one of the causes of polypharmacy. Data on 
average drug items prescribed per prescription sheet are 
presented in Table V. 
Table V. Number of average drug items prescribed per 
prescription sheet in N and BL CHC Semarang 
No Month 
Number of average drug items 
prescribed 
N CHC BL CHC 
1 January 2.77* 3.01* 
2 February 3.00* 3.09* 
3 March 2.80* 1.96 
4 April 3.12* 3.00* 
5 May 2.91* 3.16* 
6 June 3.22* 3.26* 
7 July 2.71* 3.21* 
8 August 2.68* 3.22* 
9 September 2.66* 3.38* 
10 October 3.07* 3.47* 
11 November 2.84* 3.34* 
12 December 2.95* 3.08* 
Average 2.89* 3.09* 
Note: * irrational 
The results of the calculation of the RDU percentage in 
each CHC showed different results which at N CHC 
yielded 101.44%, while the BL CHC amounted to 89.81%, 
seen from these results where both CHCs met the target 
and even exceeded. City or sub-district governments 
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provide a target of 68% in 2018 for the percentage of RDU 
(Ministry of Health of the Republic of Indonesia, 2018). 
Where the use of antibiotics in cases of ARI non-
pneumonia and non-specific diarrhea antibiotics are 
often found in their use in BL CHC, which makes it 
irrational. The results of the interview with pharmacist 
assistants at BL CHC, which still uses the 30% parameter 
in non-pneumonia ARI and non-specific diarrhea which 
makes the two diseases exceed the parameters. This is 
due to lack of information obtained by the 
pharmaceutical installation, which is associated with the 
most recent use of parameters, namely for non-
pneumonia ARI by 20% and non-specific diarrhea 8%, 
besides that for injection of Myalgia it is no longer 
allowed. This is because there is no pharmacist there at 
BL CHC, unlike N CHC where there is a pharmacist, 
where N CHC is hospitalized, besides the pharmacist's 
role is needed at any pharmacy installation especially at 
BL CHC, to prevent irrational use of drugs and 
polypharmacy in the community. Data on Percentage of 
RDU are presented in Table VI. 
Table VI. Percentage of RDU in N and BL CHC Semarang 
No Month 
% of RDU 
N CHC BL CHC 
1 January 103.57 88.43 
2 February 99.58 84 
3 March 103.37 98.03 
4 April 97.39 94.78 
5 May 101.09 87.11 
6 June 95.34 89.15 
7 July 104.77 81.3 
8 August 105.57 82.03 
9 September 105.46 86.2 
10 October 98.21 78.15 
11 November 102.52 80.51 
12 December 100.35 93.16 
Average 101.44 86.9 
 
The results of the normality test in both CHCs are said to 
be normally distributed, as well as the homogeneity test. 
Which if the two tests, namely the normality test and the 
homogeneity test are normally distributed, then proceed 
with the T-test, where the table shows the results of the T-
test which is p 0.000, which if p < 0.05 shows results that 
are not significantly different in both CHCs (Dahlan, 
2014). Statistical test results are presented in Table VII. 
Table VII. Statistical test results 
CHC Normality test Homogeneity Test T-test 
N 0.605 
0.145 0.000 
BL 0.976 
 
In the facility indicator, this study looked at the 
availability of a DOEN and 20 essential drugs at CHC. 
And it is known that both CHCs has DOEN and 20 
essential drugs. From the results of interviews with 
pharmacist assistants which in the supply of 20 essential 
drugs, the drug is given according to the needs or 
consumption of each CHC, such as the amoxicillin tab, 
amoxicillin syrup and paracetamol, while in the anti-
tuberculosis drug case or program, and for injection is 
rarely used so for each CHC it is usually only a box. 
Ministry of Health of the Republic of Indonesia targets 
100% in the implementation of DOEN, which aims to 
improve security, rational use of drugs and accuracy, 
which is at the same time to level, expand and improve 
the quality of health services (Kardela et al., 2014). Data on 
facility indicator are presented in Table VIII. 
Table VIII. Facility indicator in N and BL CHC Semarang 
No Facility indicator 
Presence of facility indicator 
N CHC BL CHC 
1 DOEN Yes Yes 
2 20 essential drugs Yes Yes 
 
CONCLUSION 
This study was successful in showing that the use of 
drugs in N CHC was rational, while for BL CHC it was 
not rational based on prescription indicators based on 
disease and facility indicators, both CHCs on facility 
indicators were stated to meet the criteria. The percentage 
of drug use in N CHC alone is 101.44%, which is better 
than BL CHC, which is only 89.81%. 
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